Legacy Advisors, LLC Medpace Holdings, Inc. Transaction History

Legacy Advisors, LLC

$978 Million
Q4 2024

A detailed history of Legacy Advisors, LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Legacy Advisors, LLC holds 4,754 shares of MEDP stock, worth $1.64 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

4,754

Previous 4,592 3.53%

Holding current value

$1.64 Million

Previous $1.53 Million 3.14%

% of portfolio

0.16%

Previous 0.17%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$308.93 - $363.58 $50,046 - $58,899	162 Added 3.53%	4,754 $1.58 Million
Q3 2024 Nov 13, 2024	SELL	$320.58 - $457.29 $49,689 - $70,879	-155 Reduced 3.27%	4,592 $1.53 Million
Q2 2024 Jul 30, 2024	BUY	$372.0 - $424.34 $21,948 - $25,036	59 Added 1.26%	4,747 $1.96 Million
Q1 2024 Apr 30, 2024	BUY	$284.87 - $413.31 $100,559 - $145,898	353 Added 8.14%	4,688 $1.89 Million
Q4 2023 Feb 12, 2024	BUY	$227.52 - $312.68 $1,137 - $1,563	5 Added 0.12%	4,335 $1.33 Million
Q3 2023 Nov 14, 2023	BUY	$233.98 - $281.67 $51,241 - $61,685	219 Added 5.33%	4,330 $1.05 Million
Q2 2023 Jul 20, 2023	BUY	$187.26 - $240.17 $36,328 - $46,592	194 Added 4.95%	4,111 $987,000
Q1 2023 May 01, 2023	BUY	$174.31 - $239.52 $14,816 - $20,359	85 Added 2.22%	3,917 $736,000
Q4 2022 Feb 01, 2023	BUY	$153.06 - $226.57 $108,060 - $159,958	706 Added 22.58%	3,832 $813,000
Q3 2022 Nov 09, 2022	BUY	$145.13 - $182.49 $110,879 - $139,422	764 Added 32.35%	3,126 $491,000
Q2 2022 Jul 25, 2022	BUY	$130.2 - $168.03 $307,532 - $396,886	2,362 New	2,362 $354,000

Others Institutions Holding MEDP

# of Institutions

623

Shares Held

25.7M

Call Options Held

74.3K

Put Options Held

79.1K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.7B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Advisors, LLC with notifications on news.

Account

Legacy Advisors, LLC Medpace Holdings, Inc. Transaction History